Surface tension gradient driven spreading on aqueous mucin solutions: a possible route to enhanced pulmonary drug delivery.
Surface tension gradient driven, or "Marangoni", flow can be used to move exogenous fluid, either surfactant dispersions or drug carrying formulations, through the lung. In this paper, we investigate the spreading of aqueous solutions of water-soluble surfactants over entangled, aqueous mucin solutions that mimic the airway surface liquid of the lung. We measure the movement of the formulation by incorporating dyes into the formulation while we measure surface flows of the mucin solution subphase using tracer particles. Surface tension forces and/or Marangoni stresses initiate a convective spreading flow over this rheologically complex subphase. As expected, when the concentration of surfactant is reduced until its surface tension is above that of the mucin solution, the convective spreading does not occur. The convective spreading front moves ahead of the drop containing the formulation. Convective spreading ends with the solution confined to a well-defined static area which must be governed by a surface tension balance. Further motion of the spread solution progresses by much slower diffusive processes. Spreading behaviors are qualitatively similar for formulations based on anionic, cationic, or nonionic surfactants, containing either hydrophilic or hydrophobic dyes, on mucin as well as on other entangled aqueous polymer solution subphases. This independence of qualitative spreading behaviors from the chemistry of the surfactant and subphase indicates that there is little chemical interaction between the formulation and the subphase during the spreading process. The spreading and final solution distributions are controlled by capillary and hydrodynamic phenomena and not by specific chemical interactions among the components of the system. It is suggested that capillary forces and Marangoni flows driven by soluble surfactants may thereby enhance the uniformity of drug delivery to diseased lungs.
Physics Department, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA.
Kevin
K
Koch
Beautia
B
Dew
Timothy E
TE
Corcoran
Todd M
TM
Przybycien
Robert D
RD
Tilton
Stephen
S
Garoff
D016503:Drug Delivery Systems; D006801:Humans; D008168:Lung / Q000187:drug effects*; D009077:Mucins / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D013500:Surface Tension; D013501:Surface-Active Agents / Q000737:chemistry*
D009077:Mucins; D011108:Polymers; D013501:Surface-Active Agents
Mod Probl Paediatr. 1976 Oct 24-27;19:141-52
1031903
Phys Fluids (1994). 2010 Jan;22(1):11901
20157445
Clin Exp Pharmacol Physiol. 2002 Aug;29(8):661-5
12099996
J Biomech Eng. 1999 Feb;121(1):89-98
10080094
Br J Pharmacol. 1996 Jun;118(3):593-8
8762082
Am Rev Respir Dis. 1987 Dec;136(6):1445-9
3688646
Eur Respir J. 2004 Jan;23(1):146-58
14738247
Ann Biomed Eng. 2005 Dec;33(12):1673
16389511
J Appl Physiol (1985). 1998 Jul;85(1):333-52
9655794
J Appl Physiol (1985). 1993 Nov;75(5):2028-39
8307856
J Appl Physiol (1985). 1995 Feb;78(2):750-6
7759450
Biochem J. 1977 May 1;163(2):363-8
869929
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Sep;70(3 Pt 1):031608
15524535
J Colloid Interface Sci. 1997 Jun 1;190(1):104-13
9241147
Ann Biomed Eng. 2005 Dec;33(12):1681-8
16389513
Am J Respir Crit Care Med. 1997 Nov;156(5):1662-8
9372691
Annu Rev Physiol. 1995;57:635-57
7778881
J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):361-70
18800882
Adv Colloid Interface Sci. 2003 Dec 1;106:183-236
14672848
Annu Rev Biomed Eng. 2001;3:421-57
11447070
J Appl Physiol (1985). 1994 Jun;76(6):2481-9
7928874